Finance

Beta
Lists
MSN:FRA
Marsh & McLennan Companies Inc
€138.20
+1.84%
(+2.50) 1D
Jun 4, 8:04:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MSN...
Open
€133.95
High
€138.20
Low
€133.95
Mkt. cap
75.80B
Avg. vol.
4.00
Volume
0.00
52-wk high
€206.30
52-wk low
€133.95
No. of employees
95K
Open
€133.95
High
€138.20
Low
€133.95
Mkt. cap
75.80B
Avg. vol.
4.00
Volume
0.00
52-wk high
€206.30
52-wk low
€133.95
No. of employees
95K
News stories
From sources across the web
Profile
Marsh & McLennan Companies, Inc., doing business as Marsh McLennan and Marsh, is a global professional services firm headquartered in New York City, with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services; Marsh Re, a reinsurance intermediary and advisor; Mercer, which provides consulting to employers for health insurance, retirement plans, and pension plans; and Oliver Wyman, including Lippincott and NERA Economic Consulting, which provides consulting services. In 2024, risk and insurance services contributed a total of 63% of revenues and 71% of operating profit, while consulting contributed 37% of revenues and 29% of operating profit. It is the largest insurance broker worldwide. The company is ranked 175th on the Fortune 500 and 267th on the Forbes Global 2000. Wikipedia
About Marsh & McLennan Companies Inc
CEOJohn Q. Doyle
Employees95K
Founded1905
HeadquartersNew York, New York, United States
SectorInsurance
Websitemarshmclennan.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.97B
6.35B
6.60B
7.60B
Cost of goods sold
3.85B
3.84B
3.78B
4.05B
Cost of revenue
3.85B
3.84B
3.78B
4.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1.25B
1.29B
1.13B
1.70B
Total operating expenses
5.10B
5.13B
4.92B
5.75B
Operating income
1.88B
1.22B
1.68B
1.85B
Other non operating income
-
-
-
-
EBT including unusual items
1.65B
1.01B
1.06B
1.58B
EBT excluding unusual items
1.65B
1.01B
1.46B
1.63B
Income tax expense
415.00M
253.00M
222.00M
395.00M
Effective tax rate
25.21%
25.05%
21.02%
24.98%
Other operating expenses
1.25B
1.29B
1.13B
1.70B
Net income
1.21B
747.00M
821.00M
1.15B
Net profit margin
17.36%
11.76%
12.45%
15.08%
Earnings per share
2.72
1.85
2.12
3.29
Interest and investment income
12.00M
25.00M
21.00M
17.00M
Interest expense
-243.00M
-237.00M
-235.00M
-240.00M
Net interest expenses
-231.00M
-212.00M
-214.00M
-223.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.11B
1.45B
1.91B
2.08B
Gain or loss from assets sale
-15.00M
-2.00M
4.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer